Cargando…

Cladribine Reduces Trans-Endothelial Migration of Memory T Cells across an In Vitro Blood–Brain Barrier

Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system (CNS) induced by immune dysregulation. Cladribine has been championed for its clinical efficacy with relatively minor side effects in treating MS. Although it is proposed that cladribine exerts an anti-migrator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ford, Rachel K., Juillard, Pierre, Hawke, Simon, Grau, Georges E., Marsh-Wakefield, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604596/ https://www.ncbi.nlm.nih.gov/pubmed/36294327 http://dx.doi.org/10.3390/jcm11206006

Ejemplares similares

Trans-Endothelial Migration of Memory T Cells Is Impaired in Alemtuzumab-Treated Multiple Sclerosis Patients
por: Nguyen, Kristy, et al.
Publicado: (2022)

Oral Cladribine Impairs Intermediate, but Not Conventional, Monocyte Transmigration in Multiple Sclerosis Patients across a Model Blood-Brain Barrier
por: Lin, Linda Y., et al.
Publicado: (2023)

Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis
por: Aglas-Leitner, F. T., et al.
Publicado: (2022)

Circulating CCR6 (+) ILC proportions are lower in multiple sclerosis patients
por: Aglas‐Leitner, Florentina, et al.
Publicado: (2022)

Peripheral B‐cell dysregulation is associated with relapse after long‐term quiescence in patients with multiple sclerosis
por: Marsh‐Wakefield, Felix, et al.
Publicado: (2022)

IgG(3) (+) B cells are associated with the development of multiple sclerosis
por: Marsh‐Wakefield, Felix, et al.
Publicado: (2020)

A robust in vitro model for trans-lymphatic endothelial migration
por: Xiong, Yanbao, et al.
Publicado: (2017)

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
por: Ceronie, Bryan, et al.
Publicado: (2018)

Activated T Cell Trans-Endothelial Migration Relies on Myosin-IIA Contractility for Squeezing the Cell Nucleus through Endothelial Cell Barriers
por: Jacobelli, Jordan, et al.
Publicado: (2013)

Application of population pharmacokinetics to cladribine
por: Lindemalm, Synnöve, et al.
Publicado: (2005)

Cladribine: Lymphopenia: case report
Publicado: (2021)

Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells
por: Chen, Xiaopeng, et al.
Publicado: (2017)

Cladribine modifies functional properties of microglia
por: Jørgensen, L. Ø., et al.
Publicado: (2020)

Cladribine: Lymphopenia: 2 case reports
Publicado: (2020)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Perillyl alcohol modulates activation, permeability and integrity of human brain endothelial cells induced by Plasmodium falciparum
por: Marin, Adriana A, et al.
Publicado: (2023)

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
por: Moser, Tobias, et al.
Publicado: (2021)

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
por: Allen-Philbey, Kimberley, et al.
Publicado: (2021)

Neutrophil trogocytosis during their trans-endothelial migration: role of extracellular CIRP
por: Takizawa, Satoshi, et al.
Publicado: (2022)

Erdheim Chester Disease treated successfully with cladribine
por: Azadeh, Natalya, et al.
Publicado: (2016)

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
por: Savic, Radojka M., et al.
Publicado: (2017)

Cladribine Tablets: A Review in Relapsing MS
por: Deeks, Emma D.
Publicado: (2018)

Expert-Agreed Practical Recommendations on the Use of Cladribine
por: Meca-Lallana, Virginia, et al.
Publicado: (2022)

Magnetic Multi-Enzymatic System for Cladribine Manufacturing
por: Cruz, Guillermo, et al.
Publicado: (2022)

Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro
por: Chen, Claire C., et al.
Publicado: (2016)

Human Neutrophil Cytoskeletal Dynamics and Contractility Actively Contribute to Trans-Endothelial Migration
por: Stroka, Kimberly M., et al.
Publicado: (2013)

Correction to: Cladribine Tablets: A Review in Relapsing MS
por: Deeks, Emma D.
Publicado: (2019)

Expert opinion on the use of cladribine tablets in clinical practice
por: Sørensen, Per Soelberg, et al.
Publicado: (2020)

COVID-19 in Cladribine-treated patient with multiple sclerosis
por: Haham, Nitsan, et al.
Publicado: (2021)

Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine
por: Hermann, Robert, et al.
Publicado: (2021)

Mechanisms of leukocyte migration across the blood–retina barrier
por: Crane, Isabel J., et al.
Publicado: (2008)

Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients
por: Ruschil, Christoph, et al.
Publicado: (2023)

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
por: Clavelou, Pierre, et al.
Publicado: (2023)

The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
por: Zabel, Brian A, et al.
Publicado: (2011)

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
por: Ruggieri, Maddalena, et al.
Publicado: (2020)

CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
por: Fournier, Antoine Philippe, et al.
Publicado: (2022)

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies
por: Laurencet, F M, et al.
Publicado: (1999)

Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
por: Schreiner, Teri L., et al.
Publicado: (2012)

Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
por: Grobost, Vincent, et al.
Publicado: (2014)

The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
por: Hermann, Robert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pb43hkg85d9i4gs4iba9fi5md4